文献速递脊柱关节炎其他结缔组织病

银屑病及银屑病关节炎相关新型自身抗体的鉴定

Identification of Novel Autoantibodies Associated With Psoriatic Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2019-04-06

本研究开发了包含风湿病典型自身抗原、皮肤抗原、炎症介质及银屑病推定自身抗原的自身抗原阵列,检测73例银屑病患者血清,发现抗LL-37和ADAMTS-L5的IgG自身抗体水平显著升高,且与PASI评分相关、反映疾病进展,并在合并PsA的患者中显著高于无PsA者。

要点

  • 抗LL-37和ADAMTS-L5的IgG自身抗体在银屑病患者血清中显著升高。
  • 这两种自身抗体水平与PASI评分相关,并反映纵向血清样本中的疾病进展。
  • 合并PsA的银屑病患者抗ADAMTS-L5和抗LL-37抗体水平显著高于无PsA者。

核心结论

  • 抗LL-37和ADAMTS-L5自身抗体可能作为银屑病和PsA的有用生物标志物及治疗靶点。

研究设计与样本

  • 开发自身抗原阵列系统,包含风湿病典型自身抗原、皮肤抗原、炎症介质及银屑病推定自身抗原。
  • 使用73例银屑病患者血清样本检测阵列抗原,并用酶联免疫吸附试验对个体自身抗体进行验证。

主要发现

  • 银屑病患者血清中多种自身抗体水平较健康对照升高,其中抗LL-37和ADAMTS-L5的IgG自身抗体显著增加。
  • 抗LL-37和ADAMTS-L5的IgG自身抗体血清水平与银屑病面积和严重程度指数(PASI)相关,并反映纵向收集血清样本中的疾病进展。
  • 合并PsA的银屑病患者抗ADAMTS-L5和抗LL-37自身抗体水平显著高于无PsA的银屑病患者。

临床怎么用

  • 抗LL-37和ADAMTS-L5自身抗体可能有助于银屑病及PsA的疾病活动监测和PsA风险识别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The autoimmune etiology in psoriasis remains to be clarified. We therefore undertook this study to identify novel pathogenic autoantigens and autoantibodies in patients with psoriasis, with the aim of shedding light on the molecular and cellular basis of the pathogenesis of psoriasis and psoriatic arthritis (PsA). METHODS: In this study, we developed an autoantigen array system that harbors a variety of antigens, including typical autoantigens in rheumatic diseases as well as skin antigens, inflammatory mediators, and putative autoantigens in psoriasis. Serum samples from patients with psoriasis (n = 73) were used to interrogate the antigens on the array. In addition, enzyme-linked immunosorbent assays of individual autoantibodies were used in validation studies. RESULTS: Levels of several autoantibodies were found to be elevated in the serum of patients with psoriasis compared to healthy controls; in particular, IgG autoantibodies against 2 novel antigens, LL-37 and ADAMTS-L5, were significantly increased in patients with psoriasis. Importantly, serum levels of IgG autoantibodies against LL-37 and ADAMTS-L5 were correlated with the Psoriasis Area and Severity Index, and reflected disease progression in longitudinally collected serum samples from patients with psoriasis. Importantly, both anti-ADAMTS-L5 and anti-LL-37 autoantibody levels were also significantly elevated in psoriasis patients with PsA compared to those without PsA, suggesting that these molecules may be involved in the pathogenesis of PsA. CONCLUSION: Our findings indicate that these identified autoantibodies may be useful biomarkers and may serve as therapeutic targets in psoriasis and PsA.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Yuan Y, Qiu J, Lin ZT, et al. Identification of Novel Autoantibodies Associated With Psoriatic Arthritis. Arthritis Rheumatol. 2019. PMID: 30618213. doi:10.1002/art.40830

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。